JPH0214038B2 - - Google Patents

Info

Publication number
JPH0214038B2
JPH0214038B2 JP57019560A JP1956082A JPH0214038B2 JP H0214038 B2 JPH0214038 B2 JP H0214038B2 JP 57019560 A JP57019560 A JP 57019560A JP 1956082 A JP1956082 A JP 1956082A JP H0214038 B2 JPH0214038 B2 JP H0214038B2
Authority
JP
Japan
Prior art keywords
cells
hirs
human
animal
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57019560A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58138395A (ja
Inventor
Kaname Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP57019560A priority Critical patent/JPS58138395A/ja
Priority to KR1019830000414A priority patent/KR900005860B1/ko
Priority to IT47689/83A priority patent/IT1167074B/it
Priority to FR8302180A priority patent/FR2521588B1/fr
Priority to GB08303870A priority patent/GB2118560B/en
Priority to CH805/83A priority patent/CH661745A5/fr
Publication of JPS58138395A publication Critical patent/JPS58138395A/ja
Publication of JPH0214038B2 publication Critical patent/JPH0214038B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP57019560A 1982-02-12 1982-02-12 ヒト免疫応答抑制因子の製造方法 Granted JPS58138395A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57019560A JPS58138395A (ja) 1982-02-12 1982-02-12 ヒト免疫応答抑制因子の製造方法
KR1019830000414A KR900005860B1 (ko) 1982-02-12 1983-02-03 인간의 면역응답 억제인자의 제조방법
IT47689/83A IT1167074B (it) 1982-02-12 1983-02-10 Procedimento per produrre l'agente soppressore di risposta immunitaria nell'uomo e prodotto ottenuto
FR8302180A FR2521588B1 (fr) 1982-02-12 1983-02-11 Procede de production de suppresseur de reponse immunitaire humain
GB08303870A GB2118560B (en) 1982-02-12 1983-02-11 Process for producing human immune response suppressor
CH805/83A CH661745A5 (fr) 1982-02-12 1983-02-14 Application d'un procede a la production de suppresseur de reponse immunitaire humain.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57019560A JPS58138395A (ja) 1982-02-12 1982-02-12 ヒト免疫応答抑制因子の製造方法

Publications (2)

Publication Number Publication Date
JPS58138395A JPS58138395A (ja) 1983-08-17
JPH0214038B2 true JPH0214038B2 (enExample) 1990-04-05

Family

ID=12002686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57019560A Granted JPS58138395A (ja) 1982-02-12 1982-02-12 ヒト免疫応答抑制因子の製造方法

Country Status (6)

Country Link
JP (1) JPS58138395A (enExample)
KR (1) KR900005860B1 (enExample)
CH (1) CH661745A5 (enExample)
FR (1) FR2521588B1 (enExample)
GB (1) GB2118560B (enExample)
IT (1) IT1167074B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
JPS63126897A (ja) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd 免疫抑制因子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS6045848B2 (ja) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 ヒト成長ホルモンの製造方法
JPS5729294A (en) * 1980-07-30 1982-02-17 Hayashibara Biochem Lab Inc Preparation of human insulin

Also Published As

Publication number Publication date
KR840003419A (ko) 1984-09-08
GB2118560B (en) 1985-06-05
FR2521588B1 (fr) 1985-10-25
GB8303870D0 (en) 1983-03-16
FR2521588A1 (fr) 1983-08-19
IT8347689A0 (it) 1983-02-10
KR900005860B1 (ko) 1990-08-13
JPS58138395A (ja) 1983-08-17
GB2118560A (en) 1983-11-02
CH661745A5 (fr) 1987-08-14
IT1167074B (it) 1987-05-06

Similar Documents

Publication Publication Date Title
KR860000897B1 (ko) 인체 에리트로포이에틴의 제조방법
JPS6030654B2 (ja) ヒトコロニ−刺激因子の製造方法
KR860001588B1 (ko) 인체 우로가스트론의 제조방법
JPS631296B2 (enExample)
JPS585671B2 (ja) ヒト卵胞刺激ホルモンの製造方法
KR870000238B1 (ko) 휴먼 유로키나아제의 제조방법
KR860000898B1 (ko) 인체 융모막성선 자극호르몬(Human Chorionic Gonadotropin)의 제조방법
KR860000894B1 (ko) 인체 인슐린의 제조방법
JPS6227048B2 (enExample)
JPS6045848B2 (ja) ヒト成長ホルモンの製造方法
JPS5825440B2 (ja) ヒトカルシトニンの製造方法
JPH0214038B2 (enExample)
JPS5823793A (ja) ヒトｔ細胞増殖因子の製造方法
KR860001576B1 (ko) 인체 세포증식 촉진활성인자의 제조방법
KR860001562B1 (ko) 인체 부갑상선 호르몬의 제조방법
KR860001591B1 (ko) 인체 부신피질 자극호르몬의 제법
JPH0214039B2 (enExample)
KR860001575B1 (ko) 인체 태반성 락토겐의 제조방법
KR890000383B1 (ko) 인체 t세포 증식인자
KR860001589B1 (ko) 인체 갑상선 자극호르몬의 제조방법
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
JPH028709B2 (enExample)
JPH0446928B2 (enExample)
JPS6323176B2 (enExample)
JPS58320B2 (ja) マウスインタ−フエロンの製造方法